Xenetic Biosciences (XBIO) Earnings Date, Estimates & Call Transcripts → Protect Yourself While There’s Still Time … (From Weiss Ratings) (Ad) Free XBIO Stock Alerts $4.09 +0.31 (+8.20%) (As of 04/26/2024 ET) Add Compare Share Share EarningsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesSEC FilingsShort InterestSocial Media Earnings SummaryUpcoming Earnings DateMay. 9EstimatedActual EPS (Mar. 21) -$0.77 Beat By $0.10 Consensus EPS (Mar. 21) -$0.87 Get Xenetic Biosciences Earnings AlertsEnter your email address below to receive the latest news and earnings results for XBIO and its competitors with MarketBeat's FREE daily newsletter. Skip Charts & View Estimated and Actual Earnings DataEarnings Per ShareRevenueXBIO Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.XBIO Estimated and Actual Revenue by Quarter Estimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Ad Stansberry ResearchMove Your Money Before May 22The SIX WORDS That Could Destroy America... And The Value of Your Savings. He predicted the dangerous rise of inflation... the death of the 60/40 portfolio... and now, this 40-year market veteran and retirement expert is stepping forward with a new must-see warning for every American. It involves the world's most powerful investors, central bankers, and America's most bitter geopolitical rivals. Here's where Dr. David Eifrig says to move your money immediately. Xenetic Biosciences Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateQ1 20241($0.79)($0.79)($0.79)Q2 20241($0.83)($0.83)($0.83)Q3 20241($0.15)($0.15)($0.15)Q4 20241($0.17)($0.17)($0.17)FY 20244($1.94)($1.94)($1.94)XBIO Earnings Date and InformationXenetic Biosciences last released its quarterly earnings data on March 21st, 2024. The reported ($0.77) earnings per share (EPS) for the quarter, beating analysts' consensus estimates of ($0.87) by $0.10. The business had revenue of $0.67 million for the quarter, compared to analyst estimates of $0.68 million. Xenetic Biosciences has generated ($2.75) earnings per share over the last year (($2.75) diluted earnings per share). Earnings for Xenetic Biosciences are expected to grow in the coming year, from ($3.43) to ($0.82) per share. Xenetic Biosciences has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, May 9th, 2024 based off prior year's report dates.Read More Xenetic Biosciences Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years Time Frame * Start Date * End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript 5/9/2024Estimated)------- 3/21/2024Q4 2023($0.87)($0.77)+$0.10($0.77)$0.68 million$0.67 million11/10/2023Q3 2023($1.12)($0.69)+$0.43($0.69)$0.46 million$0.61 million8/11/2023Q2 2023($1.13)($0.69)+$0.44($0.69)$0.44 million$0.65 million5/11/2023Q1 2023($1.10)($0.60)+$0.50($0.60)$0.41 million$0.61 million3/23/2023Q4 2022-($1.00)($1.00)($1.00)$0.18 million$0.49 million11/10/2022Q3 2022($1.80)($0.60)+$1.20($0.06)$0.35 million$0.41 million Get the Latest News and Ratings for XBIO and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Xenetic Biosciences and its competitors with MarketBeat's FREE daily newsletter. 8/12/2022Q2 2022($1.20)($1.90)($0.70)($0.19)$0.34 million$0.42 million5/12/2022Q1 2022($1.10)($1.20)($0.10)($0.12)$0.34 million$0.39 million11/11/2021-($1.20)($1.30)($0.10)($0.13)$0.20 million$0.35 million8/11/2021-($1.60)($1.30)+$0.30($0.13)$0.19 million$0.29 million 5/10/2021Q1($1.30)($1.50)($0.20)($0.15)$0.10 million$0.19 million Xenetic Biosciences Earnings - Frequently Asked Questions When is Xenetic Biosciences's earnings date? Xenetic Biosciences has not confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, May 9th, 2024 based off last year's report dates. Learn more on XBIO's earnings history. Did Xenetic Biosciences beat their earnings estimates last quarter? In the previous quarter, Xenetic Biosciences (NASDAQ:XBIO) reported ($0.77) earnings per share (EPS) to beat the analysts' consensus estimate of ($0.87) by $0.10. Learn more on analysts' earnings estimate vs. XBIO's actual earnings. How much revenue does Xenetic Biosciences generate each year? Xenetic Biosciences (NASDAQ:XBIO) has a recorded annual revenue of $2.54 million. How much profit does Xenetic Biosciences generate each year? Xenetic Biosciences (NASDAQ:XBIO) has a recorded net income of -$4.14 million. XBIO has generated -$2.75 earnings per share over the last four quarters. What is Xenetic Biosciences's EPS forecast for next year? Xenetic Biosciences's earnings are expected to grow from ($3.43) per share to ($0.82) per share in the next year. More Earnings Resources from MarketBeat Related Companies: Avenue Therapeutics Earnings Results Hoth Therapeutics Earnings Results Ayala Pharmaceuticals Earnings Results Vaccinex Earnings Results Ainos Earnings Results First Wave BioPharma Earnings Results Sonnet BioTherapeutics Earnings Results PaxMedica Earnings Results Shuttle Pharmaceuticals Earnings Results Enveric Biosciences Earnings Results Earnings Tools: Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country: U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Australia Earnings Reports Latest Articles: GE Aerospace is Ready for Liftoff After Strong EarningsTaiwan Semiconductor Earnings: AI Dominance and Future OutlookCSX Co.: The Railroad Powering Ahead with an Earnings Beat What's Driving Tesla Lower Ahead of its Earnings?Blackrock vs. State Street: Earnings in a Volatile MarketWhat to Expect From the Q1 Earnings Reporting SeasonLululemon Stock Implodes Post Earnings, Guidance Muted This page (NASDAQ:XBIO) was last updated on 4/26/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThese AI trades triggered this morning (545% return)Prosper Trading AcademyExposed: 10 CENT Crypto to Explode April 20th?True Market InsidersThe A.I. story nobody is telling you (Read ASAP)TradeSmithForget AI, Imperium Is Expected to Grow 320,00% in 3 YearsBanyan Hill PublishingHe Is Giving Away BitcoinCrypto Swap ProfitsFed launches fourth dollar overhaulStansberry ResearchMan Who Predicted 2008: “This Will be Worse.”Altimetry Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Xenetic Biosciences Inc Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
